Literature DB >> 23765532

Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.

Hans Brunnström1, Leif Johansson, Karin Jirström, Mats Jönsson, Per Jönsson, Maria Planck.   

Abstract

OBJECTIVES: To assess immunohistochemical (IHC) stains differentially expressed between different types of lung cancer.
METHODS: We evaluated 16 different IHC stains in 209 prospectively included, surgically treated primary lung cancers, including 121 adenocarcinomas, 65 squamous cell carcinomas, 15 large-cell carcinomas, 5 adenosquamous carcinomas, 2 sarcomatoid carcinomas, and 1 small-cell carcinoma, using the tissue microarray technique.
RESULTS: Cytokeratin 5 (CK5) and P63 were both positive in 10% or more of the cells in 97% of the squamous cell carcinomas, with the former being positive (<10% of the cells) in only 2 non-squamous cell carcinomas. Thyroid transcription factor 1 (TTF1) and napsin A were positive in 10% or more of the cells in 88% and 87% of the adenocarcinomas, respectively, with 94% of the adenocarcinomas being positive in at least 1 marker. Fifteen percent of the adenocarcinomas were positive for estrogen receptor.
CONCLUSIONS: CK5, TTF1, and napsin A are sensitive markers for squamous cell carcinoma and adenocarcinoma of the lung.

Entities:  

Keywords:  Adenocarcinoma; CK5; Cytokeratin; Estrogen receptor; Large-cell carcinoma; Napsin A; Neuroendocrine; P63; Squamous cell carcinoma; TTF-1

Mesh:

Substances:

Year:  2013        PMID: 23765532     DOI: 10.1309/AJCP50RDXSCSBTBO

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

Review 1.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Synchronous diagnosis of metastatic cancer to the thyroid is associated with poor prognosis.

Authors:  Jeng-Yeou Chen; I-Wen Chen; Chuen Hsueh; Tzu-Chieh Chao; Bing-Ru Gao; Jen-Der Lin
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

3.  SPROUT: spectral sparsification helps restore the spatial structure at single-cell resolution.

Authors:  Jingwan Wang; Shiying Li; Lingxi Chen; Shuai Cheng Li
Journal:  NAR Genom Bioinform       Date:  2022-09-15

4.  Lack of supportive evidence for the use of immunohistochemical staining to identify occult regional lymph node metastases in primary lung cancer.

Authors:  Per Jönsson; Leif Johansson; Maria Planck; Hans Brunnström
Journal:  Virchows Arch       Date:  2014-02-27       Impact factor: 4.064

5.  Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma.

Authors:  Rolandas Zablockis; Edvardas Žurauskas; Edvardas Danila; Vygantas Gruslys
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

6.  Upper Gastrointestinal Bleed as a Manifestation of Poorly Differentiated Metastatic Squamous Cell Carcinoma of the Lung.

Authors:  Richa Bhardwaj; Gaurav Bhardwaj; Arun Gautam; Raffi Karagozian
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 7.  Biomarker development in the precision medicine era: lung cancer as a case study.

Authors:  Ashley J Vargas; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2016-07-08       Impact factor: 60.716

8.  Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.

Authors:  Grzegorz T Gurda; Lei Zhang; Yuting Wang; Li Chen; Susan Geddes; William C Cho; Frederic Askin; Edward Gabrielson; Qing Kay Li
Journal:  Clin Transl Med       Date:  2015-04-21

9.  The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Li Li; Xiaorong Li; Jieyun Yin; Xia Song; Xiaochen Chen; Jiane Feng; Hongyu Gao; Li Liu; Sheng Wei
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

Review 10.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.